Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Hbm Bioventures Cayman Ltd
Relationship:   10% Owner
City:   Grand Cayman
State:   E9
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   28,058,903    

Indirect Shares

  1,435,154      
Direct Value   $294,816,985    

Indirect Value

  $0      
Total Shares   29,494,057      
Total Value   $294,816,985      


Icagen Inc
 $0 Harbor Brewing Company Inc
 $0 Micrus Endovascular Corp
 $0 Pacira Pharmaceuticals, Inc.
 $64,875,157 PTC Therapeutics, Inc.
 $71,877,878 Iveric Bio Inc
 $125,439,085 Apollo Endosurgery, Inc
 $27,808,360 Paratek Pharmaceuticals Inc
 $3,897,326 Nabriva Therapeutics AG
 $919,180 Werewolf Therapeutics, Inc.
 $0 Io Biotech, Inc.
 $0 Mineralys Therapeutics, Inc.
 $0 Icagen Inc
 $0 Harbor Brewing Company Inc
 $0 Micrus Endovascular Corp
 $0 Pacira Pharmaceuticals, Inc.
 $64,875,157 PTC Therapeutics, Inc.
 $71,877,878 Iveric Bio Inc
 $125,439,085 Apollo Endosurgery, Inc
 $27,808,360 Paratek Pharmaceuticals Inc
 $3,897,326 Nabriva Therapeutics AG
 $919,180 Werewolf Therapeutics, Inc.
 $0 Io Biotech, Inc.
 $0 Mineralys Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Icagen Inc ICGN 10% Owner 2005-02-08 1,200,000 2005-02-08 0    Premium*  
            Harbor Brewing Company Inc HBWOD 10% Owner 2005-03-16 3,964,615 2005-03-16 1,435,154    Premium*  
            Micrus Endovascular Corp MEND 10% Owner 2010-02-24 1,681,599 2005-06-21 0    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX 10% Owner 2013-03-25 2,233,993 0    Premium*  
            PTC Therapeutics, Inc. PTCT 10% Owner 2013-12-17 2,441,504 2013-06-25 0    Premium*  
            Iveric Bio Inc ISEE 10% Owner 2014-05-13 3,139,902 2013-09-30 0    Premium*  
            Apollo Endosurgery, Inc APEN 10% Owner 2014-09-26 2,780,836 0    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2015-05-29 1,747,680 0    Premium*  
            Nabriva Therapeutics AG NBRV 10% Owner 2017-09-14 2,334,128 0    Premium*  
            Werewolf Therapeutics, Inc. HOWL 10% Owner 2021-05-04 625,995 2021-05-04 0    Premium*  
            Io Biotech, Inc. IOBT 10% Owner 2021-11-09 2,690,545 2021-11-09 0    Premium*  
            Mineralys Therapeutics, Inc. MLYS 10% Owner 2023-02-14 3,218,106 2023-02-14 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
MLYS Mineralys Therapeutics, I... 10% Owner   –       –       •   2023-02-14 4 B $16.00 $5,000,000 D/D 312,500 3,218,106 2.45 -
MLYS Mineralys Therapeutics, I... 10% Owner   –       –       •   2023-02-14 4 A $0.00 $0 D/D 2,905,606 2,905,606 0 -
IOBT Io Biotech, Inc. 10% Owner   –       –       •   2021-11-09 4 B $14.00 $4,550,000 D/D 325,000 2,690,545 2.45 -
IOBT Io Biotech, Inc. 10% Owner   –       –       •   2021-11-09 4 A $0.00 $0 D/D 2,365,545 2,365,545 0 -
HOWL Werewolf Therapeutics, In... 10% Owner   –       –       •   2021-05-04 4 A $0.00 $0 D/D 625,995 625,995 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-09-14 4 S $8.52 $29,224 D/D (3,429) 2,334,128 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-09-13 4 S $8.54 $193,956 D/D (22,721) 2,337,557 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-09-12 4 S $8.63 $90,236 D/D (10,458) 2,360,278 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-08-31 4 S $9.50 $6,071 D/D (639) 2,370,735 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-08-08 4 S $10.50 $21,137 D/D (2,013) 2,371,374 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-08-07 4 S $10.50 $186,795 D/D (17,790) 2,373,387 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-07-28 4 S $10.51 $69,195 D/D (6,585) 2,391,177 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-07-24 4 S $10.50 $1,680 D/D (160) 2,397,762 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-07-20 4 S $10.50 $246,173 D/D (23,445) 2,397,922 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-07-19 4 S $10.50 $218,253 D/D (20,786) 2,421,367 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-07-03 4 S $10.95 $124,250 D/D (11,352) 2,571,877 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-06-30 4 S $10.94 $19,420 D/D (1,775) 2,583,229 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-06-29 4 S $10.72 $17,189 D/D (1,603) 2,585,004 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-06-28 4 S $11.10 $53,158 D/D (4,789) 2,586,697 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-06-27 4 S $10.83 $23,457 D/D (2,166) 2,591,396 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-06-01 4 S $11.27 $4,508 D/D (400) 2,593,562 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-04-28 4 S $11.03 $166,813 D/D (15,130) 2,593,962 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-04-27 4 S $11.00 $1,100 D/D (100) 2,609,092 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-04-26 4 S $11.00 $7,799 D/D (709) 2,609,192 0 -
NBRV Nabriva Therapeutics AG 10% Owner   –       –       •   2017-04-21 4 S $11.04 $28,937 D/D (2,622) 2,609,901 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed